Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02135965 · ClinicalTrials.gov registry record · Early Phase 1
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
A Early Phase 1 study of Healthy Volunteers, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT02135965: Completed Early Phase 1 study of Healthy Volunteers, sponsored by Pennington Biomedical Research Center.
NCT02135965 is a Early Phase 1 study of Healthy Volunteers that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 8 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02135965, a Early Phase 1 study of Healthy Volunteers, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to define a ratio of Caffeine and albuterol that gives a synergistic increase in metabolic rate.
Primary Outcome
The order of which 8 combinations will be determined randomly (like flipping a coin) and neither the participant nor the study personnel will know what is in the pills. The identity of the pills can be determined by breaking the code in the case of an emergency. 1. Albuterol 2mg; 2. Albuterol 4mg; 3. Caffeine 100mg; 4. Caffeine 200mg; 5. Albuterol 2mg and Caffeine 100mg; 6. Albuterol 2mg and Caffeine 200mg; 7. Albuterol 4mg and Caffeine 100mg; 8. Albuterol 4mg and Caffeine 200mg. The data will b
Conditions Studied
Interventions
- DRUG 2mg of Albuterol
- DRUG 4mg of Albuterol
- DRUG 100mg of Caffeine
- DRUG 200mg of Caffeine
- DRUG Albuterol 2mg & Caffeine 100mg
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2009-04 |
| Est. Completion | 2011-08 |
| Phase | Early Phase 1 |
What the finished NCT02135965 record still lists
NCT02135965 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 5 interventions - of which 2mg of Albuterol is the first listed.
NCT02135965 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT02135965 about?
NCT02135965 is a clinical study titled "Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate". The purpose of this study is to define a ratio of Caffeine and albuterol that gives a synergistic increase in metabolic rate.
What is the current status of trial NCT02135965?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2009-04. Estimated completion is 2011-08.
What conditions does trial NCT02135965 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT02135965?
The interventions under investigation include: 2mg of Albuterol (DRUG), 4mg of Albuterol (DRUG), 100mg of Caffeine (DRUG), 200mg of Caffeine (DRUG), Albuterol 2mg & Caffeine 100mg (DRUG).
Who is sponsoring clinical trial NCT02135965?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02135965 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02135965's enrollment target sits among peer trials
8 269th of 283 higher than 7 of 283 other Healthy Volunteers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis
RECRUITING · Early Phase 1
-
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
RECRUITING · Early Phase 1
-
Sustained Release Oral Formulation for Treatment of Parkinson's Disease
RECRUITING · Early Phase 1
-
Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects
COMPLETED · Early Phase 1
-
Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein
COMPLETED · Early Phase 1
-
Adaptive Optics Retinal Imaging
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia